Cargando…
Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity
Autores principales: | Ferreira, Ana Maria Da Costa, Schneider-Stock, Regine, Aiello, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021606/ https://www.ncbi.nlm.nih.gov/pubmed/35463962 http://dx.doi.org/10.3389/fmolb.2022.859821 |
Ejemplares similares
-
Editorial: Innovation and transformation of chronic airway diseases
por: Zhao, Rui, et al.
Publicado: (2022) -
Editorial: Synthetic biology in Vertebrate Model system: New clinical and preclinical translational applications
por: Wang, Xu
Publicado: (2023) -
Investigation of TNBC in vitro Antiproliferative Effects of Versatile Pirrolo[1,2-a]quinoxaline Compounds
por: Perri, Mariarita, et al.
Publicado: (2019) -
Editorial: Novel Molecular Mechanisms and Innovative Therapeutic Approaches for Age-Associated Diseases
por: Sun, Leming, et al.
Publicado: (2022) -
Editorial: Oligomerization and fibrillation of amyloid peptides: Mechanism, toxicity and inhibition
por: Qian, Zhenyu, et al.
Publicado: (2022)